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Abstract 
Objective: To compare the predictive ability of estimated fetal weight (EFW) percentiles, 
according to seven growth standards, to detect fetuses at risk for adverse perinatal outcomes. 
Methods: This retrospective cohort study included 3,437 African-American women. Population-
based (Hadlock, INTERGROWTH-21st, WHO, FMF), ethnic specific (NICHD), customized 
(GROW) and African American customized (PRB/NICHD) growth standards were applied to the 
last available scan prior to delivery. Prediction performance indices and relative risk (RR), carried 
by an EFW<10th and EFW>90th percentile according to each standard, were calculated for 
individual and composite adverse perinatal outcomes. The sensitivity at a fixed (10%) false-
positive rate (FPR), as well as the partial (FPR<10%) and full area under the ROC curves (AUC), 
were compared among the standards. 
Results: 1) Ten percent (341/3437) of the neonates were classified as small-for-gestational-age 
(SGA) at birth, and of these, 16.4% (56/341) had at least one adverse perinatal outcome. SGA 
neonates were at a 1.5-fold increased risk of any adverse outcome (p<0.05); 2) the screen-positive 
rate (EFW<10th percentile) of growth standards varied from 6.8% (NICHD) to 24.4 % (FMF); 3) 
EFW<10th percentile, according to all standards, was associated with an increased risk for all 
adverse perinatal outcomes considered (all, p<0.05); 4) the highest RRs carried by an EFW<10th 
percentile were: 5.1 for perinatal mortality (WHO); 5.0 for perinatal hypoglycemia (NICHD); 3.4 
for mechanical ventilation (NICHD); 2.9 for Apgar score <7 at 5 minutes (GROW); 2.7 for 
Neonatal Intensive Care Unit (NICU) admission (NICHD); and 2.5 for the composite adverse 
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perinatal outcome (NICHD). Although confidence intervals overlapped among all standards for 
each individual outcome, the RR for NICHD [2.46(1.9-3.1)] was higher than the one for FMF 
1.47(1.2-1.8) for the composite outcome. 5) the sensitivity for the composite adverse perinatal 
outcome varied substantially among standards (15% for NICHD to 32% for FMF) given mostly to 
differences in the FPR, and they subsided when the FPR was set to the same value (10%); 6) the 
comparison of the AUC revealed a significant improvement for the PRB/NICHD (AUC=0.70) 
compared to Hadlock (AUC=0.66) and FMF (AUC=0.64) standards for the prediction of perinatal 
mortality; complementarily, the evaluation of the partial AUC (FPR<10%) revealed that the 
INTERGROWTH-21 standard had an advantage over the Hadlock standard for NICU admissions 
and mechanical ventilation (all, p<0.05). 7) Although large-for-gestational-age (LGA) fetuses 
(EFW>90th) were also at risk of adverse perinatal outcomes, according to INTERGROWTH-21 
(RR=1.4) and Hadlock (RR=1.7) standards, much fewer cases (2-5 fold) were detected by an LGA 
compared to an SGA screening by the same standards.    
Conclusions: Fetuses with an EFW<10th as well as those with EFW>90th percentile were at 
increased risk of adverse perinatal outcomes according to all, or some of the seven standards, 
respectively. The relative risk carried by an EFW<10th percentile for the composite adverse 
perinatal outcome was higher for the most stringent (NICHD) than the least stringent (FMF) 
standard for SGA screening. The complementary analysis based on the AUC suggests slightly 
improved detection of adverse perinatal outcomes by more recent population-based 
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(INTERGROWTH-21st) and customized (PRB/NICHD) standards compared to the Hadlock and 
FMF standards.    
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INTRODUCTION  
Low and high birthweight is associated with increased perinatal morbidity and mortality.1-17 
Therefore, antenatal surveillance of fetal growth is essential to promote close monitoring and to 
suggest potential measures to reduce the risk (e.g., induction of labor).18-27 Indeed, antenatal 
detection of high-risk fetuses is associated with a significant reduction in stillbirth and perinatal 
morbidity rates.28-32 
Antenatal screening for growth restriction using ultrasound relies on the estimation of fetal weight 
(EFW) and comparison to a reference, also known as a growth chart or growth standard. The 
10th/90th percentile cut-offs, first suggested by Battaglia and Lubchenco33 for neonatal birth weight, 
and later adopted by Hadlock et al.34 for EFW, are used to identify fetuses at risk for adverse 
outcomes.35-37  
After Hadlock’s “one-size-fits-all” growth chart was introduced, Gardosi et al.38 proposed an 
adjustable fetal growth chart in which percentile curves are shifted up or down to account for non-
pathologic factors such as maternal height, weight, parity, race/ethnicity, and fetal sex.39-45 The 
effects of these factors were assumed to be proportionally constant during gestation, and 
adjustment coefficients were estimated from birthweight data in specific populations.46-52 More 
recent customized standards do not rely on the proportionality assumption and allow these effects 
to vary among the specific centile curves.53  
The potential of customized birthweight standards to improve identification of neonates at risk for 
adverse perinatal morbidity and mortality has been well established.54-67 Nevertheless, recent 
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initiatives to develop growth standards did not perform customization of growth charts or 
customized only for a subset of non-pathologic factors known to affect fetal growth. For example, 
the World Health Organization (WHO) growth standard only customizes by fetal sex, 68-70 while 
the National Institute of Child Health and Human Development (NICHD) developed ethnic-
specific charts without adjusting for other factors.71 In addition, the INTERGROWTH-21st project 
proposed a “one-size-fits-all” standard, without customization, yet the decision not to adjust for 
fetal sex was based on ethical grounds.72-76  Similarly, the Fetal Medicine Foundation (FMF) 
proposed a non-customized fetal growth standard by reconciling fetal weight and birthweight data 
in a multi-ethnic population that included a large majority (69%) of white women 77. 
Given the plethora of fetal growth standards available, with their intrinsic differences in 
the design and in the characteristics of the populations from which they are derived, it is important 
to determine how these differences impact their utility. Therefore, we conducted a retrospective 
study, comparing the ability of an EFW<10th and EFW>90th percentile to identify fetuses at risk 
of perinatal morbidity and mortality, according to the seven aforementioned growth standards.   
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METHODS  
Study Design 
A retrospective cohort study was conducted at the Center for Advanced Obstetrical Care and 
Research of the Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child 
Health and Human Development (NICHD), National Institutes of Health, U.S. Department of 
Health and Human Services. All patients included in this study were enrolled in research protocols 
approved by the Human Investigation Committee of Wayne State University and the Institutional 
Review Board of NICHD. 
The study population consisted of pregnant women who had at least one ultrasound evaluation 
prior to delivery and for whom perinatal information was available. Women with multiple 
gestations, those with known fetal anomalies or chromosomal aberrations, and those who were lost 
to follow-up or delivered elsewhere were excluded from the study. Detailed demographic data, 
medical history, and pregnancy outcomes were extracted from the patients' electronic medical 
records.  
Outcomes 
The adverse perinatal outcomes considered in the study were as follows: 1) perinatal mortality; 2) 
Neonatal Intensive Care Unit (NICU) admission; 3) Apgar scores <7 at 5 minutes after delivery; 
4) neonatal hypoglycemia; 5) the need for mechanical ventilation; 6) neonatal hypothermia; 7) 
meconium aspiration syndrome; and 8) composite adverse perinatal outcome, involving one or 
more of the outcomes above. Only outcomes affecting 20 or more of the 3437 patients were 
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analyzed individually; otherwise, they contributed only to the analysis of the composite adverse 
perinatal outcome. 
Perinatal mortality was defined as stillbirth or neonatal death within 7 days of birth.78 Stillbirth 
was defined as death of the fetus diagnosed after 20 weeks of gestation confirmed by ultrasound 
examination prior to delivery.   NICU admission was defined as documented newborn admission 
to the NICU at any time during the hospitalization. Apgar scores <7 at 5 minutes after delivery 
were calculated according to an accepted method for reporting the status of the newborn 
immediately after birth.79, 80 Neonatal hypoglycemia was defined as a glucose level <45 mg/dL.81 
Mechanical ventilation was defined when a ventilation machine was used to improve the exchange 
of air between the lungs and the atmosphere. Neonatal hypothermia defined as a neonatal axillary 
temperature less than 36.5°C.78, 82 Meconium aspiration syndrome was diagnosed in infants who 
had dyspnea, tachycardia, and need for supplemental oxygen by hours of life, and diffuse irregular 
patchy infiltrates on chest radiographs.83 Of note, infants with meconium below the vocal cords 
but with no clinical or radiographic evidence of disease were not diagnosed with aspiration 
syndrome. 
Fetal growth screening  
Screen-positive for small- (SGA) and large (LGA) -for-gestational-age was based on an EFW<10th 
and EFW>90th percentile, respectively, for each standard. The observed EFW at last scan prior to 
delivery was derived using the formula published for each individual standard based on biometrical 
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parameters [i.e., abdominal circumference (AC), femur length (FL), head circumference (HC), and 
biparietal diameter (BPD)], as follows:  
Hadlock 1: EFW was calculated with a three-parameter Hadlock equation (HC, AC, and FL) 84, 
used by other recent growth standards (NICHD, WHO, PRB/NICHD, FMF), and compared to the 
same centile curves reported by Hadlock et al. in 199134 using a four-parameter equation.  
Hadlock 2: EFW was calculated using a four-parameter formula (AC, FL, HC, and BPD) originally 
reported by Hadlock et al.,84 and the observed value was compared to the centile curves derived 
for this EFW formula.34 This fetal weight assessment was the one used clinically for the detection 
of SGA in the study population.  
INTERGROWTH-21st: EFW was calculated from AC and HC using the equation proposed by the 
authors, and observed values were compared to the centile curves reported.75, 85 
The World Health Organization (WHO) fetal growth standard: EFW was calculated based on a 
three-parameter Hadlock formula (HC, AC, FL) 84 and compared to the reference centile without 
customization for fetal sex.68-70 
The Eunice Kennedy Shriver National Institute of Child Health and Human Development 
(NICHD): EFW was calculated using the three-parameter Hadlock formula (HC, AC, FL) 84 and 
compared to the centile curves derived for the African-American population.71  
Gestational Related Optimal Weight (GROW): EFW was calculated using the three-parameter 
Hadlock formula (HC, AC, FL)84 and a corresponding customized percentile was obtained using 
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the GROW software (V8.0.1).86 Customization was made for ethnic origin, maternal height, 
weight and parity, and fetal sex.  
Perinatology Research Branch / Eunice Kennedy Shriver National Institute of Child Health and 
Human Development (PRB/NICHD): EFW was calculated using the three-parameter Hadlock 
formula (HC, AC, FL),84 and corresponding customized centiles were calculated using the R 
package available at http://bioinformaticsprb.med.wayne.edu/software/prb-nichd-fetal-growth-
standard/. Customization of the growth centiles was made for maternal height, weight and parity, 
and fetal sex.53  
Fetal Medicine Foundation (FMF): EFW was calculated based on a three-parameter Hadlock 
formula (HC, AC, FL) 84 and compared to the reference centiles described in Nicolaides et al. 77.  
 
Statistical analysis  
We evaluated the sensitivity and specificity of the screening test as well as the relative risk (RR) 
carried by an EFW<10th and EFW>90th percentile according to each standard for each outcome. 
When screening for SGA, for standards providing an exact percentile for any given observed EFW 
value (GROW, Hadlock, INTERGROWTH-21st, PRB/NICHD, FMF), Receiver Operating 
Characteristic (ROC) curves were constructed and the full and partial (FPR<10%) areas under the 
ROC curves (AUC) were calculated, and compared to Hadlock 1, considered as a reference using 
the pROC package 87. For these standards, the sensitivity at a 10% false-positive rate was also 
determined for each outcome for SGA screening.  
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RESULTS  
Characteristics of the study population 
The study population included 3,437 African-American women. The characteristics of the study 
population are summarized in Table 1. Of those, 478 women delivered preterm (<37 weeks of 
gestation) and 2,959 women delivered at term. The mean gestational age at delivery was 38.5 ± 
2.4 weeks, and the mean interval from sonographic EFW measurement to delivery was 3.6 weeks 
± 3.51 weeks.   
The median maternal body mass index of the population was 27.5 [interquartile range (IQR) 22.9-
33.7], and 18.5% of women (634/3437) were smokers. About 10% (341/3,437) of the neonates 
were classified as SGA and 7.2% (250/3,437) as LGA according to the United States national 
reference for birthweight standards reported by Alexander et al.88 The cohort included 11.7% 
(403/3,437) neonates diagnosed with at least one adverse perinatal outcome, with 219 of the 403 
neonates being delivered preterm. The group of 20 cases with perinatal mortality included 11 cases 
of stillbirth and 9 cases of neonatal death. 
 Of all the neonates with at least one adverse perinatal outcome, 13.9% of neonates (56/403) were 
SGA (birthweight <10th centile). The RR of adverse perinatal outcomes carried by a birthweight 
<10th centile is shown using a forest plot in Figure S1. The RR of the composite adverse perinatal 
outcome associated with an SGA delivery was 1.5 [95% CI 1.15-1.94], and the highest RR for an 
individual outcome reached 3.49 [95% CI 2.23–5.46] for neonatal hypoglycemia.  
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Association between EFW<10th and adverse perinatal outcomes 
Screen positive rates:  
There was large variability in the screen-positive rate (EFW<10th percentile) across the different 
standards: 6.8% for NICHD, 9.4% for GROW, 11.6% for WHO, 13.2% for INTERGROWTH-
21st, 13.5% for PRB/NICHD, 16.2% for Hadlock 2, 16.5% for Hadlock 1 and 24.4% for FMF. 
Relative risk: 
An EFW<10th centile at the last scan before delivery (screen positive) was associated with an 
increased risk in individual and composite adverse neonatal outcomes for all standards (Figure 1, 
Table 2, and Table S1). The RR for the composite adverse perinatal outcome was significantly 
lower for the least stringent standard (FMF) RR=1.47 [95% confidence interval (CI) 1.2-1.8] 
compared to the most stringent standard (NICHD) RR=2.46 [95% CI 1.9-3.1]. The highest RRs of 
an individual adverse outcome were for perinatal mortality 5.05 [95% CI 2.08-12.29] (WHO); 
neonatal hypoglycemia 5.0 [95% CI 3.27-7.83] (NICHD); mechanical ventilation 3.39 [95% CI 
2.43-4.74] (NICHD); Apgar score <7 at 5 minutes 2.88 [95% CI 1.80-4.63] (GROW); and NICU 
admission 2.68 [95% CI 2.01-3.57] (NICHD). Of note, for all individual outcomes, the CIs of the 
RR overlapped among standards. Nonetheless, there were notable differences in RR estimates 
among standards for specific outcomes. For instance, for perinatal mortality, the lowest RR was 
2.18 (Hadlock 1), and the highest RR was 5.05 (WHO). 
Sensitivity and specificity 
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The sensitivity of EFW<10th centile for the composite adverse perinatal outcome ranged between 
15% (NICHD) and 32% (FMF) with these two standards having the highest (27%) and lowest 
(16%) positive predictive values, respectively (see Table S1). The highest sensitivities for 
individual outcomes at the 10th percentile cut-off were obtained using the FMF standard: neonatal 
hypoglycemia 46%; perinatal mortality 45%; mechanical ventilation 40%; NICU admission 35%; 
and Apgar score <7 at 5 minutes 35%. The higher sensitivities for FMF standard were typically 
accompanied by lower specificities. The specificity for the composite adverse perinatal outcome 
ranged between 77% (FMF) and 94% (NICHD). The highest specificities for individual outcomes 
were as follows: neonatal hypoglycemia 94% (NICHD); perinatal mortality 91% (GROW); 
mechanical ventilation 94% (NICHD); NICU admission 94% (NICHD); and Apgar score <7 at 5 
minutes 93% (NICHD) (Table S1).  
Of note, while the sensitivity values discussed above were obtained using a 10th percentile cut-off 
for each standard to define screen-positive, the full spectrum of sensitivities can be seen in Figure 
2.  
Sensitivity at a fixed false-positive rate 
To determine how much of the differences in sensitivities among standards described above are 
due to different stringency levels of the different standards (hence, specificity), we also determined 
the sensitivity at a fixed (10%) false-positive rate for standards providing exact percentiles. Indeed, 
there was a high similarity in sensitivity among standards when the false-positive rate was set to 
the same value (10%) (Figure 2). For instance, the sensitivity (at 10% FPR) for the composite 
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adverse outcome varied only from 19.4% (GROW) to 21.7% (INTERGROWTH-21st) across the 
five standards shown in Figure 2, while for perinatal mortality, it was the same (30%) for all six 
standards shown in Figure 2. To reach the same false-positive rate (10%) for the composite adverse 
outcome, it was required to use a 6.6  percentile cut-off for the Hadlock-1 standard, 8.0 for both 
PRB/NICHD and INTERGROWTH-21st, 11.2 for GROW, and 2.0 percentile cut-off for FMF 
standard.  
ROC curve analysis 
The AUC statistics for individual and composite outcomes were overall either failed (0.5-0.6) or 
poor (0.6-0.7) and rather similar among the different growth standards (Figure 3 and Table 3). 
However, the PRB/NICHD standard had a higher AUC (0.70) for the prediction of perinatal 
mortality compared to Hadlock 1 (0.66) and FMF (0.64) (p<0.05). The AUC was also slightly 
higher for Hadlock 2 standard (AUC=0.67) compared to FMF (AUC=0.64) for perinatal mortality 
(Table S3), and for INTERGROWTH-21st standard (AUC=0.58) compared to FMF (AUC=0.56) 
for Apgar <7 at 5 min. 
Nevertheless, when considering only the part of the ROC curve for which the FPR<10% and 
computing the partial area under the curve, we noted a slightly higher values for the 
INTERGROWTH-21st standard compared to the Hadlock 1 and FMF standards for the prediction 
of NICU admission (all, p<0.05) (Figure 3, Table 3, Table S3). Similarly, for the partial AUC was 
slightly higher for INTERGROWTH-21st standard compared to FMF standard for hypoglycemia 
(Figure 3, Table S3). The use of the partial AUC is motivated by the fact that it is more important 
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for the different standards to have higher sensitivity at a low and, hence, more clinically relevant 
false-positive rate. 
 
Association between EFW>90th and adverse perinatal outcomes 
The screening rates for LGA were overall smaller than those for SGA, and they also varied greatly 
among standards: Hadlock 1 and 2 (2.9%), GROW (6.4%), INTERGROWTH-21st (7%), 
PRB/NICHD (9%), FMF (9.6%), WHO (10.2%), and NICHD (12.5%). Among the seven 
standards considered, LGA screening by INTERGROWTH-21st (RR=1.4) and Hadlock (RR=1.7) 
standards led to a significant association with the composite adverse perinatal outcome, yet 
sensitivity was 2- to 5-fold lower (5% for Hadlock and 10% for INTERGROWTH-21st) compared 
to SGA screening with the same standards (see Table S2). LGA fetuses were also at risk of 
hypoglycemia according to the Hadlock standard (RR=2.9) with only 8% (sensitivity) of cases 
being detected.        
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DISCUSSION 
Customized vs. non-customized standards 
More than 100 fetal growth standards were proposed for fetal growth assessment41. Several studies 
suggested that customized fetal growth 38, 45, 89, 90 and birthweight 54-67 assessment better predicts 
morbidity, while other studies found the opposite or were inconclusive. 39, 40, 55, 57, 66, 91-105 Sovio at 
al.66 reported that customized third trimester growth assessment did not improve the association 
with neonatal morbidity compared to non-customized standards, while Blue et al. 103 reported 
superior performance of non-customized standards than ethnic-specific standards. We therefore 
compared seven fetal growth standards for prediction of adverse perinatal outcomes and evaluated 
the extent to which differences in sensitivity are due to different overall stringencies of the 
standards (how low or high the 10th centile curve is and, hence, the screen-positive rate) as opposed 
to 1) differences in the shape of the 10th percentile curve and/or 2) factors considered in the 
customization that lead to different percentiles across standards for the same observed EFW. 
Comparison of screen-positive rates  
The screen-positive rate for SGA and LGA varied considerably with NICHD African American 
standard identifing only 6.8% as SGA and 12.5% as LGA; hence, this standard can be considered 
overall too low for our population. By contrast, Hadlock’s chart identified 16.5% of fetuses as 
SGA and only 2.9% as LGA; hence, this standard can be considered too high. Although the 10th 
centile of the FMF standard was the highest compared to all standards, resulting in the largest 
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screen positive rate for SGA (24.4%), the 90th centile of this chart was similar to the one of the 
other standards and classified 9.6% of fetuses as LGA, based on the last availble scan.  
 While a previous study65 in a U.S. population identified a large difference in screen-positive rates 
of birthweight <10th percentile between the INTERGROWTH-21st (3.5%) and GROW (11.1%) 
standards, the assessment of EFW presented herein resulted in less discrepancy (11.6%, GROW; 
13.5%, INTERGROWTH-21st) likely due to differences in the populations.  
Comparison of relative risks  
Sovio at al.23 reported that a third-trimester EFW<10th percentile was associated with a 1.6-fold 
increase in the risk of neonatal morbidity, which is similar to the 1.7 estimate derived herein with 
Hadlock’s standard. Moreover, we showed that fetuses with EFW<10th percentile were at 
increased risk of individual adverse perinatal outcomes according to all standards, with the highest 
risk estimate being for perinatal mortality (WHO standard, RR=5.05). Overall, the most stringent 
standard for SGA screening (NICHD) resulted in consistently higher relative risk estimates for 
adverse perinatal outcomes, while the least stringent standard (FMF) had the lowest relative risk 
estimates. The differences in relative risk among these most extreme standards were significant 
for the composite adverse perinatal outcome, yet the overlapping confidence intervals among all 
other standards impeded drawing conclusions regarding the superiority of one standard over 
another for individual adverse perinatal outcomes.  
Comparison of area under the ROC curve  
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To complement the typical assessment based on relative risk and sensitivity for adverse neonatal 
outcomes,65 we also compared the full and partial AUC of low EFW percentiles. While sensitivity 
may vary due to differences in screen-positive rates, the AUC analysis considers all possible cut-
offs and compares standards in terms of their ability to rank fetuses from the most (lowest 
percentile) to the least (highest percentile) at risk of sub-optimal growth. Even for non-customized 
standards, such differences in the reordering of the fetuses with respect to their risk are expected 
due to the shape of the 10th centile curve, which, for the same screen-positive rate, alters the balance 
of preterm and term fetuses being screened positive in a given cohort. Differences in performance 
of growth standards are also expected due differences in pregnancy characteristics considered in 
customization (if any) and analytical approaches and populations used to establish the standards 
106. 
The AUC for prediction of perinatal mortality with the PRB/NICHD standard was higher than for 
Hadlock 1 and FMF standards, yet the improvement emerged at FPR>15%; hence, a difference 
was not detected when comparing the partial area under the curve (FPR<10%). Of note, using a 
20th percentile cut-off on the PRB/NICHD growth standard identifies one-half of fetuses at risk of 
perinatal mortality and one-third of those at risk of any adverse perinatal outcome considered 
herein (Figure 3). 
Based on the partial AUC, the INTERGROWTH-21st standard showed superiority over Hadlock 
and FMF standards for individual perinatal outcomes. This can be understood since fetuses at risk 
for these outcomes had lower percentiles according to INTERGROWTH-21st compared to the 
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Hadlock and FMF standards, resulting in higher sensitivity at low FPR (Figure 3, Table 3, Table 
S3). Therefore, the ROC curve-based analyses provided a perspective not attainable by simply 
comparing relative risk at the 10% EFW cut-off.   
Strengths and limitations 
This is the first study to compare seven fetal growth standards used worldwide, for prediction of 
adverse perinatal outcomes in the same population. The limitations are: 1) the population 
comprised only African-American women, and future studies are required to determine whether 
findings extrapolate to other populations; 2) the population included a wide range of gestational 
ages at the last ultrasound scan that was related to the actual distribution of gestational age at 
delivery; 3) the current study evaluated several but not all adverse perinatal outcomes due to their 
low frequencies; 4) the cohort included in this study was derived from a larger set of 4,001 
pregnancies used to develop the PRB/NICHD standard; hence, prediction performance estimates 
for this particular standard may be biased.  
Conclusion 
This study demonstrated that differences in stringency (and hence FPR) among standards explain 
the variability in sensitivity and relative risk of adverse perinatal outcomes. When considering a 
wider range of FPR by ROC curve analysis, the recent international (INTERGROWTH-21st) and 
customized (PRB/NICHD) standards seem to improve detection of fetuses at risk of some adverse 
perinatal outcomes compared to Hadlock and FMF standards in a African-American population. 
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Although LGA fetuses were also at risk of adverse perinatal outcomes, much fewer cases will be 
detected by LGA than SGA screening.  
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Figure legends 
Figure 1: Association between an EFW<10th percentile and adverse perinatal outcomes. 
Relative risk and 95% confidence intervals are shown using a forest plot. Estimated fetal weight 
(EFW) and percentile values are calculated as described in the Methods section.  
Figure 2: Sensitivity at fixed false-positive rate.  For standards providing an exact percentile 
value, the test positive is based on a cut-off chosen so that the false-positive rate is 10% for each 
outcome considered. Sensitivity and 95% confidence intervals are shown using a forest plot.   
Figure 3: Receiver Operating Characteristic (ROC) curves for prediction of adverse 
neonatal outcomes. The ROC curves are constructed from the percentile values derived from each 
standard, and the area under the curves (AUC) is shown in the legend. The following outcomes 
are considered: A – Composite adverse perinatal outcomes; B – Perinatal mortality; C – NICU 
admission; D – Apgar score <7 at 5 minutes; E – Hypoglycemia; F – Mechanical ventilation. 
Figure S1: Association between SGA at birth and adverse perinatal outcomes. Relative risk 
and 95% confidence intervals are shown using a forest plot. Small-for-gestational-age (SGA) is 
defined according to the lower 10th percentile of the United States national reference for 
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Table 1: Characteristics of the study population (n=3,437). Data are given as median 
[interquartile range] or number (%). Maternal height and weight were recorded in inches and 
pounds and then converted into cm and kg, respectively, prior to analysis. 
Characteristic  Statistic 
Maternal age (y) 23 [20-27] 
Parity   
     Nulliparous 1259 (36.6%) 
     Multiparous 2178 (63.4%) 
Body mass index 27.5 [22.9-33.7] 
Height (cm) 162.6(157.5-167.6) 
Weight (kg) 72.6(60.8-90.3) 
Smoking status   
     Smoker 634 (18.5%) 
     Non-smoker 2803 (81.5%) 
Gestational age at delivery (weeks) 39.0 [38.0-39.9] 
Interval from scan to delivery (weeks) 2.6 [1.0-5.3] 
Preterm delivery 478 (13.9 %) 
Mode of delivery   
     Vaginal  2475 (72.0%) 
     Caesarean section 962 (28.0%) 
Sex   
     Male 1755 (51.1%) 
     Female 1682 (48.9%) 
Birthweight (g) 3145 [2790-3465] 
SGA by Alexander  341 (9.9%) 
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Table 2: Relative risk carried by an EFW<10th percentile for adverse perinatal outcome. Data are shown as relative risk estimates 
and 95% confidence intervals. * number of cases delivered preterm (<37 weeks). 
  Hadlock 1 Hadlock 2 PRB/NICHD NICHD WHO 
INTERGROWTH-




[219*] 1.72 (1.4-2.12) 
1.77 (1.44-

























2.68) 2.68 (2.01-3.57) 
2.27 (1.76-





























3.44) 3.39 (2.43-4.74) 
2.55 (1.86-
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Table 3: Area under the ROC curves for prediction of adverse perinatal outcomes by a low 
EFW percentile compared to Hadlock 1 standard. Area under the ROC curve (AUC) for each 
standard (%) was compared against the Hadlock 1 standard. AUC values in bold are significantly 
(p<0.05) higher compared to Hadlock 1 standard by at least 2%. Partial AUC values in bold are 
significantly (p<0.05) higher compared to Hadlock 1 standard by at least 0.2%. 

















PRB/NICHD 55 0.781 1.5 0.541 
INTERGROWTH-21st   54.7 0.675 1.6 0.036 
GROW 54.1 0.107 1.4 0.405 







PRB/NICHD 69.9 0.011* 2.6 0.803 
INTERGROWTH-21st   65.7 0.827 2.4 0.495 
GROW 67.5 0.554 2.3 0.256 







PRB/NICHD 56.9 0.856 1.6 0.520 
INTERGROWTH-21st   56.2 0.285 1.7 0.017 
GROW 55.9 0.148 1.5 0.576 
FMF 56.2 <0.001* 1.5 0.440 






PRB/NICHD 58.1 0.287 1.5 0.101 
INTERGROWTH-21st   58.4 0.272 1.6 0.179 
GROW 56.3 0.246 1.4 0.708 








PRB/NICHD 60.6 0.194 1.9 0.064 
INTERGROWTH-21st   59.8 0.843 2.2 0.003 
GROW 59.1 0.295 1.8 0.656 
FMF 59.1 <0.001* 1.8 0.550 
Hypoglycemia Hadlock2 61.4 61.7 0.151 2.5 2.5 0.828 
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PRB/NICHD 61.4 0.557 2.3 0.198 
INTERGROWTH-21st   62.2 0.656 2.7 0.072 
GROW 60.8 0.423 2.5 0.546 
FMF 61.5 0.425 2.4 0.362 
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